Prostate Cancer Prevention Trial identifies men most likely to undergo challenging study procedures
Healthy men participating in the Prostate Cancer Prevention Trial  who actively participate in all steps of the clinical trial are most likely to undergo a biopsy, according to a study published in Cancer Epidemiology, Biomarkers and Prevention - a journal of the American Association for Cancer Research. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 13, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson Opens Diagnostic Imaging Center in West Houston
Committed to bringing its cancer care services, clinical trials and standard of care closer to patients, The University of Texas MD Anderson Cancer Center is opening a full-service diagnostic imaging center in West Houston on Sept. 2. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 11, 2014 Category: Cancer & Oncology Source Type: news

Researchers discover a metabolic mechanism for resistant pancreatic cancer
Knock out a genetic mutation that's a driving force behind pancreatic cancer and a few cells quietly hunker down in the resulting scar tissue, nibbling on themselves to survive before roaring back as resistant disease that taps the cell's normal powerhouses to thrive.   (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 11, 2014 Category: Cancer & Oncology Source Type: news

Study predicts hepatitis C will become a rare disease in 22 years
Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 4, 2014 Category: Cancer & Oncology Source Type: news

Protein ZEB1 Promotes Breast Tumor Resistance to Radiation Therapy
One protein with the even more out-there name of  ZEB1 (zinc finger E-box binding homeobox 1), is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a study at The University of Texas MD Anderson Cancer Center in Houston. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 4, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson Announces First Latin American Clinical Partnership
The University of Texas MD Anderson Cancer Center has announced a partnership with Hospital Israelita Albert Einstein (HIAE) to pioneer multidisciplinary patient care in Brazil and advance MD Anderson's mission to eliminate cancer globally. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 1, 2014 Category: Cancer & Oncology Source Type: news

Same cancer, different time zone
Just as no two people possess the same genetic makeup, a recent study has shown that no two single tumor cells in breast cancer patients have an identical genome.In fact, depending on the tumor cell, they grow at dramatically different speeds, according to a study led by Nicholas Navin,  Ph.D. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 30, 2014 Category: Cancer & Oncology Source Type: news

"Father of Tamoxifen" to Join MD Anderson
The University of Texas MD Anderson Cancer Center is pleased to announce that one of the world's preeminent experts in breast cancer research and treatment, V. Craig Jordan, Ph.D., will join the institution's efforts to end cancer.  Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 21, 2014 Category: Cancer & Oncology Source Type: news

Study finds diagnosing physicians influence treatment decisions for prostate cancer patients
New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 14, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson Ranked #2 in Annual U.S. News & World Report Survey
According to the annual "Best Hospitals" survey conducted by U.S. News & World Report, The University of Texas MD Anderson Cancer Center is ranked No. 2 in cancer care this year. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 14, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson researchers discover new route for ovarian cancer spread
Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and metastasize to other organs, scientists at The University of Texas MD Anderson Cancer Center report in Cancer Cell. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 14, 2014 Category: Cancer & Oncology Source Type: news

Pseudogenes May Provide Clearer Understanding of Biomarkers
Alas, the thankless pseudogene.Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 7, 2014 Category: Cancer & Oncology Source Type: news

Study Shows Restored Immunity for Cancer-Related Fungal Infections
A study at The University of Texas MD Anderson Cancer Center used the Sleeping Beauty gene transfer system to modify T cells in hopes of fighting major life-threatening infections caused by invasive Aspergillus fungus.   (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 7, 2014 Category: Cancer & Oncology Source Type: news

Ending Cancer: MD Anderson's bold Moon Shots Program aims for a cure
The University of Texas MD Anderson Cancer Center returns to Aspen July 21 for its 16th annual Making Cancer History® seminar. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 3, 2014 Category: Cancer & Oncology Source Type: news

Study points to higher risk of breast cancer progression in obese women
A new study comparing obese mice with breast cancer and biological changes in breast cancer samples from patients appears to indicate the tie between obesity and higher risk for death. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 27, 2014 Category: Cancer & Oncology Source Type: news